510(k) K120986
K120986 is an FDA 510(k) premarket notification submitted by Focus Diagnostics, Inc. for the device "STRATIFY JCV DXSELECT". The FDA issued a decision of Substantially Equivalent on August 16, 2012. The device falls under product code OYP (Anti-Jcv Antibody Detection Assay), a Class II device regulated under 21 CFR 866.3336. Focus Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 16, 2012
- Date Received
- April 2, 2012
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Anti-Jcv Antibody Detection Assay
- Device Class
- Class II
- Regulation Number
- 866.3336
- Review Panel
- MI
- Submission Type
The anti-jcv antibody detection assay is intended for the detection of antibodies to the john cunningham virus (jcv) in serum or plasma samples from multiple sclerosis (ms) and crohn's disease (cd) patients receiving immunomodulatory therapies.